A phase I/II dose escalation and efficacy trial of GVAX prostate cancer vaccine [Cancer vaccine-GVAX] in patients with metastatic hormone-refractory prostate cancer
Phase of Trial: Phase I/II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Tumour cell vaccine-GVAX (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cell Genesys
- 23 Jul 2008 Cell Genesys announces publication of final results from this trial; results are consistent with thiose seen in the first phase II trial and sup[port the phase III trial program.
- 18 Dec 2007 Status changed from in progress to completed.
- 04 Apr 2007 Final survival data presented.